← Back to Clinical Trials
Recruiting NCT06844019

NCT06844019 Birth & Breastfeeding Support Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06844019
Status Recruiting
Phase
Sponsor Herlev Hospital
Condition Breastfeeding
Study Type OBSERVATIONAL
Enrollment 1,628 participants
Start Date 2025-01-06
Primary Completion 2027-01-06

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,628 participants in total. It began in 2025-01-06 with a primary completion date of 2027-01-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn about the effects of birth practices such as cesarean section and vacuum assisted birth and diseases such as gestational diabetes and preeclampsia on exclusive breastfeeding. The main question it aims to answer is: • Does cesarean section, vacuum assisted birth, gestational diabetes and preeclampsia affect exclusive breastfeeding three months after birth? Participants answer eight online survey questions. One survey is distributed before birth and the remaining seven surveys are distributed after birth at three, seven and four-teen days, as well as one, three, six and twelve months after birth.

Eligibility Criteria

Inclusion Criteria: 18 years, intention to breastfeed, single gestation, reads and understands Danish - Exclusion Criteria: Twin gestation, less than 18 years, no intention to breastfeed, does not read and understand Danish \-

Contact & Investigator

Central Contact

Dorrit Vizel-Schwartz, MSN, CNM, IBCLC, Ph.d.-student

✉ dorrit.vizel-schwartz@regionh.dk

📞 +45 3188 2258

Principal Investigator

Thomas Bergholt, Professor, PhD, MSc

PRINCIPAL INVESTIGATOR

Herlev & Gentofte Hospital

Frequently Asked Questions

Who can join the NCT06844019 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Breastfeeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06844019 currently recruiting?

Yes, NCT06844019 is actively recruiting participants. Contact the research team at dorrit.vizel-schwartz@regionh.dk for enrollment information.

Where is the NCT06844019 trial being conducted?

This trial is being conducted at Herlev, Denmark.

Who is sponsoring the NCT06844019 clinical trial?

NCT06844019 is sponsored by Herlev Hospital. The principal investigator is Thomas Bergholt, Professor, PhD, MSc at Herlev & Gentofte Hospital. The trial plans to enroll 1,628 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology